Jak3-independent trafficking of the common γ chain receptor subunit: Chaperone function of Jaks revisited

Molecular and Cellular Biology

Volumn 24, Issue 11, 2004, Pages 5039-5049

  Hofmann, Sigrun R ^a   Lam, Albert Q ^a,c   Frank, Stephan ^a,d   Zhou, Yong Jie ^a   Ramos, Haydeé L ^a   Kanno, Yuka ^a   Agnello, Davide ^a   Youle, Richard J ^b   O'Shea, John J ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CYTOKINE RECEPTOR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; INTERLEUKIN 2 RECEPTOR; JANUS KINASE; JANUS KINASE 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN COS7; CELLULAR DISTRIBUTION; ENDOSOME; ENZYME STRUCTURE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; LYSOSOME; MEMBRANE TRANSPORT; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; COS CELLS; HELA CELLS; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; JANUS KINASE 3; MOLECULAR CHAPERONES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; TIME FACTORS;

ANIMALIA; JANUS;

EID: 2442710342     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.11.5039-5049.2004     Document Type: Article

References (37)

1. Cacalano, N. A., T. S. Migone, F. Bazan, E. P. Hanson, M. Chen, F. Candotti, J. J. O'Shea, and J. A. Johnston. 1999. Autosomal SCID caused by a point mutation in the N terminus of Jak3: mapping of the Jak3-receptor interaction domain. EMBO J. 18:1549-1558.
2. Candotti, F., S. A. Oakes, J. A. Johnston, S. Gillani, R. F. Schumacher, P. Mella, M. Fiorini, A. G. Ugazio, R. Badolato, L. D. Notarangelo, F. Bozzi, P. Macchi, D. Strina, P. Vezzoni, R. M. Blaese, J. J. O'Shea, and A. Villa. 1997. Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 90:3996-4003.
3. Cao, X., C. A. Kozak, Y. J. Liu, M. Noguchi, E. O'Connell, and W. J. Leonard. 1993. Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression. Proc. Natl. Acad. Sci. USA 90:8464-8468.
4. Chen, M., A. Cheng, F. Candotti, Y. J. Zhou, A. Hymel, A. Fasth, L. D. Notarangelo, and J. J. O'Shea. 2000. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol. Cell. Biol. 20:947-956.
5. Chen, M., A. Cheng, Y. Q. Chen, A. Hymel, E. P. Hanson, L. Kimmel, Y. Minami, T. Taniguchi, P. S. Changelian, and J. J. O'Shea. 1997. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. USA 94:6910-6915.
6. Gadina, M., D. Hilton, J. A. Johnston, A. Morinobu, A. Lighvani, Y. J. Zhou, R. Visconti, and J. J. O'Shea. 2001. Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 13:363-373.
7. Gauzzi, M. C., G. Barbieri, M. F. Richter, G. Uze, L. Ling, M. Fellous, and S. Pellegrini. 1997. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc. Natl. Acad. Sci. USA 94:11839-11844.
8. Haan, C., H. Is'harc, H. M. Hermanns, H. Schmitz-Van de Leur, I. M. Kerr, P. C. Heinrich, J. Grotzinger, and I. Behrmann. 2001. Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction. J. Biol. Chem. 276:37451-37458.
9. Hemar, A., A. Subtil, M. Lieb, E. Morelon, R. Hellio, and A. Dautry-Varsat. 1995. Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and rate of the receptor alpha, beta, and gamma chains. J. Cell Biol. 129:55-64.
10. Huang, L. J., S. N. Constantinescu, and H. F. Lodish. 2001. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol. Cell 8:1327-1338.
11. Ihle, J. 2001. Pathways in cytokine regulation of hematopoiesis. Ann. N. Y. Acad. Sci. 938:129-130.
12. Karaghiosoff, M., H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler, H. Pircher, B. McCoy, C. Bogdan, T. Decker, G. Brem, K. Pfeffer, and M. Muller. 2000. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13:549-560.
13. Kawamura, M., D. W. McVicar, J. A. Johnston, T. B. Blake, Y. Q. Chen, B. K. Lal, A. R. Lloyd, D. J. Kelvin, J. E. Staples, J. R. Ortaldo, et al. 1994. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc. Natl. Acad. Sci. USA 91:6374-6378.
14. Kerr, I. M., A. P. Costa-Pereira, B. F. Lillemeier, and B. Strobl. 2003. Of JAKs, STATs, blind watchmakers, jeeps, and trains. FEBS Lett. 546:1-5.
15. Leonard, W. J. 2001. Role of Jak kinases and STATs in cytokine signal transduction. Int. J. Hematol. 73:271-277.
16. Lippincott-Schwartz, J., L. Yuan, C. Tipper, M. Amherdt, L. Orci, and R. D. Klausner. 1991. Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67:601-616.
17. Luo, H., P. Rose, D. Barber, W. P. Hanratty, S. Lee, T. M. Roberts, A. D. D'Andrea, and C. R. Dearolf. 1997. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol. Cell. Biol. 17:1562-1571.
18. Macchi, P., A. Villa, S. Giliani, M. G. Sacco, A. Frattini, F. Porta, A. G. Ugazio, J. A. Johnston, F. Candotti, J. J. O'Shea, et al. 1995. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-68.
19. Manning, G., D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam. 2002. The protein kinase complement of the human genome. Science 298: 1912-1934.
20. Morelon, E., and A. Dautry-Varsat. 1998. Endocytosis of the common cytokine receptor gamma chain. Identification of sequences involved in internalization and degradation. J. Biol. Chem. 273:22044-22051.
21. Neumann, D., M. H. Yuk, H. F. Lodish, and G. Z. Lederkremer. 1996. Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms. Biochem. J. 313(Pt. 2):391-399.
22. Notarangelo, L. D., P. Mella, A. Jones, G. de Saint Basile, G. Savoldi, T. Cranston, M. Vihinen, and R. F. Schumacher. 2001. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency. Hum. Mutat. 18:255-263.
23. O'Shea, J. J., M. Gadina, and R. D. Schreiber. 2002. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109(Suppl.): S121-S131.
24. Radtke, S., H. M. Hermanns, C. Haan, H. Schmitz-Van De Leur, H. Gascan, P. C. Heinrich, and I. Behrmann. 2002. Novel role for Janus kinase 1 in the regulation of oncostatin M receptor surface expression. J. Biol. Chem. 277: 11237-11305.
25. Ragimbeau, J., E. Dondi, A. Alcover, P. Eid, G. Uze, and S. Pellegrini. 2003. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J. 22:537-547.
26. Richter, M. F., G. Dumenil, G. Uze, M. Fellous, and S. Pellegrini. 1998. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1. J. Biol. Chem. 273: 24723-24729.
27. Russell, S. M., J. A. Johnston, M. Noguchi, M. Kawamura, C. M. Bacon, M. Friedmann, M. Berg, D. W. McVicar, B. A. Witthuhn, O. Silvennoinen, et al. 1994. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042-1045.
28. Russell, S. M., N. Tayebi, H. Nakajima, M. C. Riedy, J. L. Roberts, M. J. Aman, T. S. Migone, M. Noguchi, M. L. Markert, R. H. Buckley, et al. 1995. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800.
29. Saharinen, P., K. Takaluoma, and O. Silvennoinen. 2000. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol. Cell. Biol. 20:3387-3395.
30. Saijo, K., S. Y. Park, Y. Ishida, H. Arase, and T. Saito. 1997. Crucial role of Jak3 in negative selection of self-reactive T cells. J. Exp. Med. 185:351-356.
31. Sohn, S. J., K. A. Forbush, N. Nguyen, B. Witthuhn, T. Nosaka, J. N. Ihle, and R. M. Perlmutter. 1998. Requirement for Jak3 in mature T cells: its role in regulation of T-cell homeostasis. J. Immunol. 160:2130-2138.
32. Supino-Rosin, L., A. Yoshimura, H. Altaratz, and D. Neumann. 1999. A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation. Eur. J. Biochem. 263:410-419.
33. c and Jak3 double-deficient mice. Int. Immunol. 12:123-132.
34. Thomis, D. C., and L. J. Berg. 1997. Peripheral expression of Jak3 is required to maintain T lymphocyte function. J. Exp. Med. 185:197-206.
35. Velazquez, L., K. E. Mogensen, G. Barbieri, M. Fellous, G. Uze, and S. Pellegrini. 1995. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J. Biol. Chem. 270:3327-3334.
36. Zhou, Y. J., M. Chen, N. A. Cusack, L. H. Kimmel, K. S. Magnuson, J. G. Boyd, W. Lin, J. L. Roberts, A. Lengi, R. H. Buckley, R. L. Geahlen, F. Candotti, M. Gadina, P. S. Changelian, and J. J. O'Shea. 2001. Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol. Cell 8:959-969.
37. Zhou, Y. J., E. P. Hanson, Y. Q. Chen, K. Magnuson, M. Chen, P. G. Swann, R. L. Wange, P. S. Changelian, and J. J. O'Shea. 1997. Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity. Proc. Natl. Acad. Sci. USA 94:13850-13855.